Schrader Joachim, Lüders Stephan, Diener Hans-Christoph
St.-Josefs-Hospital, Cloppenburg, Germany.
Herz. 2003 Dec;28(8):707-16. doi: 10.1007/s00059-003-2512-x.
Hypertension is the most important risk factor for stroke and vascular dementia. Antihypertensive treatment reduces stroke risk by 40%. Most probably, all antihypertensive drugs are equally effective with the exception of alpha blockers. One study showed superiority of an angiotensin (AT) II antagonist versus beta blocker in patients with hypertension and left ventricular hypertrophy. Blood pressure is increased in many patients with acute stroke. In this phase, sudden drops in blood pressure should be avoided. All guidelines concerning antihypertensive treatment in acute stroke are not based on evidence. For secondary prevention, the combination of an angiotensin- converting enzyme (ACE) inhibitor and diuretic reduced strokes by 28% after transient ischemic attack (TIA) or a first stroke. Whether this is a drug-specific effect or due to lowering blood pressure per se is investigated at the moment. Antihypertensive treatment can reduce the incidence of vascular dementia and cognitive impairment.
高血压是中风和血管性痴呆最重要的危险因素。抗高血压治疗可使中风风险降低40%。除α受体阻滞剂外,很可能所有抗高血压药物的效果都相当。一项研究表明,在高血压合并左心室肥厚的患者中,血管紧张素(AT)II拮抗剂优于β受体阻滞剂。许多急性中风患者的血压会升高。在此阶段,应避免血压突然下降。所有关于急性中风抗高血压治疗的指南并非基于证据。对于二级预防,血管紧张素转换酶(ACE)抑制剂和利尿剂联合使用可使短暂性脑缺血发作(TIA)或首次中风后的中风发生率降低28%。目前正在研究这是药物特异性作用还是仅仅由于降低血压本身所致。抗高血压治疗可降低血管性痴呆和认知障碍的发生率。